DEFINING LENALIDOMIDE-SENSITIVE AND/OR REFRACTORY - PATIENTS IN MULTIPLE MYELOMA MANAGEMENT

Video in which Prof.  Mohamad Mohty, Sorbonne hospital St Antoine (Paris) explains the significance of lenalidomide in treating patients with multiple myeloma.
In the video he distinguishes between lenalidomide-sensitive and lenalidomide refractory patients.